Evaluation of 2 screening strategies for early identification of patients with axial spondyloarthritis in primary care

J Rheumatol. 2011 Nov;38(11):2452-60. doi: 10.3899/jrheum.110070. Epub 2011 Sep 15.

Abstract

Objective: To evaluate 2 referral strategies for axial spondyloarthritis (SpA) in patients with chronic low back pain at the primary care level.

Methods: Referral physicians (n = 259) were randomly assigned to either Strategy 1 or Strategy 2 in order to refer patients with chronic back pain (duration > 3 months), age at onset of back pain < 45 years, and no diagnosis of axial SpA, to a cooperating rheumatologist (n = 43). According to Strategy 1, suitable patients were referred if at least 1 of the following screening criteria was present: inflammatory back pain, HLA-B27, or sacroiliitis detected by imaging. According to Strategy 2, patients were referred if 2 out of 5 criteria were positive: the same 3 criteria from Strategy 1 and additionally a positive family history of ankylosing spondylitis (AS) or a good treatment response to nonsteroidal antiinflammatory drugs. The final diagnosis of the rheumatologist was used as the "gold standard."

Results: In total, 560 consecutively referred patients were included in the analysis. Among 318 patients referred by Strategy 1, 41.8% (95% CI 36.5%-47.3%) were diagnosed with definite axial SpA. Among 242 patients referred by the second strategy, definite axial SpA was diagnosed in 36.8% (95% CI 31.0%-43.0%) of the cases.

Conclusion: Both referral strategies demonstrated comparable performance in identification of patients with axial SpA. Strategy 1 might be preferred as an easy and reliable screening method for axial SpA at the primary care level.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Back Pain / epidemiology*
  • Comorbidity
  • Early Diagnosis*
  • Female
  • HLA-B27 Antigen / blood
  • Humans
  • Male
  • Mass Screening / methods*
  • Middle Aged
  • Pedigree
  • Primary Health Care / methods*
  • Sacroiliitis / epidemiology
  • Spondylarthritis / diagnosis*
  • Spondylarthritis / drug therapy
  • Spondylarthritis / epidemiology*
  • Spondylitis, Ankylosing / genetics
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • HLA-B27 Antigen